Blueblood Ventures Ltd
Blueblood Ventures is engaged in the business of equity investment and trading in equity, derivatives, currencies,futures and options and commodities ,Venture capital funding and other financial products.
- Market Cap ₹ 3.32 Cr.
- Current Price ₹ 11.1
- High / Low ₹ /
- Stock P/E 19.5
- Book Value ₹ 50.8
- Dividend Yield 0.00 %
- ROCE 3.56 %
- ROE 1.12 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.22 times its book value
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Finance Industry: Finance & Investments
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Operating Profit |
OPM % |
Interest |
Depreciation |
Profit before tax |
Tax % |
EPS in Rs |
Raw PDF |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2016 | Mar 2017 | |
---|---|---|
0.72 | 2.73 | |
-10.13 | -1.67 | |
Operating Profit | 10.85 | 4.40 |
OPM % | 1,506.94% | 161.17% |
0.00 | 0.00 | |
Interest | 10.63 | 4.11 |
Depreciation | 0.04 | 0.03 |
Profit before tax | 0.18 | 0.26 |
Tax % | 27.78% | 34.62% |
0.12 | 0.17 | |
EPS in Rs | 0.40 | 0.57 |
Dividend Payout % | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | 279% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | 42% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 3% |
3 Years: | % |
1 Year: | 0% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | 1% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2016 | Mar 2017 | |
---|---|---|
Equity Capital | 3.00 | 3.00 |
Reserves | 12.10 | 12.23 |
100.20 | 114.77 | |
22.28 | 28.23 | |
Total Liabilities | 137.58 | 158.23 |
0.08 | 0.07 | |
CWIP | 0.00 | 0.00 |
Investments | 0.13 | 5.78 |
137.37 | 152.38 | |
Total Assets | 137.58 | 158.23 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2016 | Mar 2017 | |
---|---|---|
-59.78 | -5.00 | |
0.01 | -5.52 | |
59.38 | 10.44 | |
Net Cash Flow | -0.39 | -0.07 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2016 | Mar 2017 | |
---|---|---|
Debtor Days | 0.00 | 0.00 |
Inventory Days | ||
Days Payable | ||
Cash Conversion Cycle | 0.00 | 0.00 |
Working Capital Days | 58,268.19 | 16,586.78 |
ROCE % | 3.56% |
Documents
Announcements
- Pursuant To Regulation 30 Of The Securities Exchange Board Of India (LODR) Requirements, 2015 Approves The Standalone Audited Financial Results For The Financial Year Ended 2023-2024 Along With Auditor Report. 27 May
-
Announcement under Regulation 30 (LODR)-Change in Directorate
27 May - Securities Exchange Board of India ( listing obligations and Disclosures Requirements) Regulations, 2015, Mr. Pushpendra Surana ceases to be a Director of the Company with …
- Board Meeting Outcome for The Board Has Decided To Approve The Standalone Annual Audited Financials Results For The Financial Year Ended 2023-24 Along With Auditor Report Thereon. 27 May
- Closure of Trading Window 18 May
- Board Meeting Intimation for To Consider And Approve Audited Standalone Financials Results And Resignation Of Mr. Pushpendra Surana 18 May